Papers: 29 Oct 2012 - 5 Nov 2012 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Editors' Pick The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells. Brüstle A, Brenner D, Knobbe CB, Lang PA, Virtanen C, Hershenfield BM, Reardon C, Lacher SM, Ruland J, Ohashi PS, et al. J Clin Invest. 2012 Nov 1. Epub 1969 Dec 31. PMID: 23114599. Abstract Editors' Pick Soluble axoplasm enriched from injured CNS axons reveals the early modulation of the actin cytoskeleton. Garland P, Broom LJ, Quraishe S, Dalton PD, Skipp P, Newman TA, Perry HV PLoS One. 2012; 7(10):e47552. Epub 2012 Oct 24. PMID: 23115653. Abstract Mast cells and inflammation. Frenzel L, Hermine O Joint Bone Spine. 2012 Oct 29. PMID: 23116710. Abstract Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis. Moscarello MA, Lei H, Mastronardi FG, Winer S, Tsui H, Li Z, Ackerley C, Zhang L, Raijmakers R, Wood DD Dis Model Mech. 2012 Nov 1. PMID: 23118341. Abstract How Patients With Multiple Sclerosis Perceive Cognitive Slowing. Roberg BL, Bruce JM, Lovelace CT, Lynch S Clin Neuropsychol. 2012 Nov 1. PMID: 23116235. Abstract Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease. Codarri L, Greter M, Becher B Trends Immunol. 2012 Oct 29. PMID: 23116549. Abstract Prognostic factors of acute partial transverse myelitis. Gajofatto A, Benedetti M D Arch Neurol. 2012 Nov 1; 69(11):1523-4. PMID: 23117920. Abstract Imaging multiple sclerosis and other neurodegenerative diseases. Inglese M, Petracca M Prion. 2012 Nov 1; 7(1). PMID: 23117868. Abstract Preliminary study on the association of AQP4 promoter polymorphism with anti-aquaporin-4 antibody positivity in Southern Han Chinese patients with idiopathic demyelinating disorders of central nervous system. Mai W, Hu X, Lu Z, Qiu W, Peng F, Wang Y J Neuroimmunol. 2012 Oct 29. PMID: 23116879. Abstract Prognostic factors of acute partial transverse myelitis-reply. Bourre B Arch Neurol. 2012 Nov 1; 69(11):1523-4. PMID: 23117921. Abstract Can we predict the evolution of an unpredictable disease like multiple sclerosis? Bergamaschi R Eur J Neurol. 2012 Oct 31. PMID: 23114082. Abstract Moyamoya disease can masquerade as multiple sclerosis. Dorfman LJ, Fischbein NJ, Woodard JI, Choudhri O, Bell-Stephens TE, Steinberg GK Neurologist. 2012 Nov; 18(6):398-403. PMID: 23114675. Abstract Antenarratives to inform health care research: exploring workplace illness disclosure for people with multiple sclerosis (MS). Vickers MH J Health Hum Serv Adm. 2012 Fall; 35(2):170-206. PMID: 23113417. Abstract Biologics-induced autoimmune diseases. Perez-Alvarez R, Pérez-De-Lis M, Ramos-Casals M, on behalf of the BIOGEAS study group Curr Opin Rheumatol. 2012 Oct 30. PMID: 23114587. Abstract Psychiatric disorders in neurology. Sinanović O Psychiatr Danub. 2012 Oct; 24 Suppl 3:331-5. PMID: 23114812. Abstract Glial progenitor cell-based treatment and modeling of neurological disease. Goldman SA, Nedergaard M, Windrem MS Science. 2012 Oct 26; 338(6106):491-5. PMID: 23112326. Abstract Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis. Dagley LF, Emili A, Purcell AW Proteomics Clin Appl. 2012 Oct 30. PMID: 23112123. Abstract Constraint-Induced Movement Therapy for the Lower Extremities in Multiple Sclerosis: Case Series with 4-Year Follow-up. Mark VW, Taub E, Uswatte G, Bashir K, Cutter GR, Bryson CC, Bishop-McKay S, Bowman MH Arch Phys Med Rehabil. 2012 Oct 27. PMID: 23111280. Abstract Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis. Brown RA, Narayanan S, Arnold DL Neuroimage. 2012 Oct 27. PMID: 23110887. Abstract Type I IFN receptor controls activated TYK2 in the nucleus: Implications for EAE therapy. Ahmed CM, Noon-Song EN, Kemppainen K, Pascalli MP, Johnson HM J Neuroimmunol. 2012 Oct 27. PMID: 23110939. Abstract Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Pertwee RG Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5; 367(1607):3353-63. PMID: 23108552. Abstract Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats. Das A, Kelly Guyton M, Smith A, Iv G W, McDowell ML, Holmes C, Matzelle DD, Ray SK, Banik NL J Neurochem. 2012 Oct 25. PMID: 23106593. Abstract Paucity of natural killer and cytotoxic T cells in human neuromyelitis optica lesions. Saadoun S, Bridges LR, Verkman AS, Papadopoulos MC Neuroreport. 2012 Dec 19; 23(18):1044-7. PMID: 23108041. Abstract The discovery of natalizumab, a potent therapeutic for multiple sclerosis. Steinman L J Cell Biol. 2012 Oct 29; 199(3):413-6. PMID: 23109666. Abstract Epileptic seizures in multiple sclerosis: a population-based survey in Iran. Etemadifar M, Abtahi S-H, Roomizadeh P Acta Neurol Belg. 2012 Oct 31. Epub 2012 Oct 31. PMID: 23111776. Abstract [2011: What's new in dysimmune neuropathies.] Kuntzer T Rev Neurol (Paris). 2012 Oct 26. PMID: 23107879. Abstract Risk of venous thrombosis in patients with major illnesses: Results from the MEGA study. Ocak G, Vossen CY, Verduijn M, Dekker FW, Rosendaal FR, Cannegieter SC, Lijfering WM J Thromb Haemost. 2012 Oct 26. PMID: 23106832. Abstract Myeloid microvesicles are a marker and therapeutic target for neuroinflammation. Verderio C, Muzio L, Turola E, Bergami A, Novellino L, Ruffini F, Riganti L, Corradini I, Francolini M, Garzetti L, et al. Ann Neurol. 2012 Oct; 72(4):610-24. PMID: 23109155. Abstract Risk of fractures in patients with multiple sclerosis: A population-based cohort study. Dobson R, Ramagopalan S, Giovannoni G, Bazelier MT, de Vries F Neurology. 2012 Oct 30; 79(18):1934-5. PMID: 23109656. Abstract Resident glial cell activation in response to perispinal inflammation leads to acute changes in nociceptive sensitivity: implications for the generation of neuropathic pain. Tenorio G, Kulkarni A, Kerr BJ Pain. 2012 Sep 27. PMID: 23103436. Abstract Quantitative analysis of cerebrospinal fluid brain derived neurotrophic factor in the patients with multiple sclerosis. Mashayekhi F, Salehi Z, Jamalzadeh H R Acta Medica (Hradec Kralove). 2012; 55(2):83-6. PMID: 23101271. Abstract Sleep disturbances in patients with multiple sclerosis. Pokryszko-Dragan A, Bilińska M, Gruszka E, Biel L, Kamińska K, Konieczna K Neurol Sci. 2012 Oct 30. Epub 2012 Oct 30. PMID: 23109097. Abstract Estimating the proportion of variation in susceptibility to multiple sclerosis captured by common SNPs. Watson CT, Disanto G, Breden F, Giovannoni G, Ramagopalan SV Sci Rep. 2012; 2:770. Epub 2012 Oct 25. PMID: 23105968. Abstract Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis? Mezei Z, Bereczki D, Racz L, Csiba L, Csepany T Neuropsychiatr Dis Treat. 2012; 8:465-73. Epub 2012 Oct 23. PMID: 23118540. Abstract Consequences of neurologic lesions assessed by Barthel Index after Botox(®) injection may be underestimated. Dionyssiotis Y, Kiourtidis D, Karvouni A, Kaliontzoglou A, Kliafas I Ther Clin Risk Manag. 2012; 8:385-91. Epub 2012 Oct 19. PMID: 23112577. Abstract Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters. Lee D-H, Gold R, Linker RA Int J Mol Sci. 2012; 13(9):11783-803. Epub 2012 Sep 18. PMID: 23109883. Abstract Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. O'Gorman C, Lucas R, Taylor B Int J Mol Sci. 2012; 13(9):11718-52. Epub 2012 Sep 18. PMID: 23109880. Abstract Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases. Hristodorov D, Mladenov R, Huhn M, Barth S, Thepen T Toxins (Basel). 2012 Sep; 4(9):676-94. Epub 2012 Sep 14. PMID: 23105975. Abstract Erythropoietin: new directions for the nervous system. Maiese K, Chong Z Z, Shang Y C, Wang S Int J Mol Sci. 2012; 13(9):11102-29. Epub 2012 Sep 06. PMID: 23109841. Abstract Prenatal vitamin d deficiency induces an early and more severe experimental autoimmune encephalomyelitis in the second generation. de Abreu D A F, Landel V, Barnett AG, McGrath J, Eyles D, Feron F Int J Mol Sci. 2012; 13(9):10911-9. Epub 2012 Aug 30. PMID: 23109828. Abstract
Editors' Pick The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells. Brüstle A, Brenner D, Knobbe CB, Lang PA, Virtanen C, Hershenfield BM, Reardon C, Lacher SM, Ruland J, Ohashi PS, et al. J Clin Invest. 2012 Nov 1. Epub 1969 Dec 31. PMID: 23114599. Abstract
Editors' Pick Soluble axoplasm enriched from injured CNS axons reveals the early modulation of the actin cytoskeleton. Garland P, Broom LJ, Quraishe S, Dalton PD, Skipp P, Newman TA, Perry HV PLoS One. 2012; 7(10):e47552. Epub 2012 Oct 24. PMID: 23115653. Abstract
Mast cells and inflammation. Frenzel L, Hermine O Joint Bone Spine. 2012 Oct 29. PMID: 23116710. Abstract
Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis. Moscarello MA, Lei H, Mastronardi FG, Winer S, Tsui H, Li Z, Ackerley C, Zhang L, Raijmakers R, Wood DD Dis Model Mech. 2012 Nov 1. PMID: 23118341. Abstract
How Patients With Multiple Sclerosis Perceive Cognitive Slowing. Roberg BL, Bruce JM, Lovelace CT, Lynch S Clin Neuropsychol. 2012 Nov 1. PMID: 23116235. Abstract
Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease. Codarri L, Greter M, Becher B Trends Immunol. 2012 Oct 29. PMID: 23116549. Abstract
Prognostic factors of acute partial transverse myelitis. Gajofatto A, Benedetti M D Arch Neurol. 2012 Nov 1; 69(11):1523-4. PMID: 23117920. Abstract
Imaging multiple sclerosis and other neurodegenerative diseases. Inglese M, Petracca M Prion. 2012 Nov 1; 7(1). PMID: 23117868. Abstract
Preliminary study on the association of AQP4 promoter polymorphism with anti-aquaporin-4 antibody positivity in Southern Han Chinese patients with idiopathic demyelinating disorders of central nervous system. Mai W, Hu X, Lu Z, Qiu W, Peng F, Wang Y J Neuroimmunol. 2012 Oct 29. PMID: 23116879. Abstract
Prognostic factors of acute partial transverse myelitis-reply. Bourre B Arch Neurol. 2012 Nov 1; 69(11):1523-4. PMID: 23117921. Abstract
Can we predict the evolution of an unpredictable disease like multiple sclerosis? Bergamaschi R Eur J Neurol. 2012 Oct 31. PMID: 23114082. Abstract
Moyamoya disease can masquerade as multiple sclerosis. Dorfman LJ, Fischbein NJ, Woodard JI, Choudhri O, Bell-Stephens TE, Steinberg GK Neurologist. 2012 Nov; 18(6):398-403. PMID: 23114675. Abstract
Antenarratives to inform health care research: exploring workplace illness disclosure for people with multiple sclerosis (MS). Vickers MH J Health Hum Serv Adm. 2012 Fall; 35(2):170-206. PMID: 23113417. Abstract
Biologics-induced autoimmune diseases. Perez-Alvarez R, Pérez-De-Lis M, Ramos-Casals M, on behalf of the BIOGEAS study group Curr Opin Rheumatol. 2012 Oct 30. PMID: 23114587. Abstract
Psychiatric disorders in neurology. Sinanović O Psychiatr Danub. 2012 Oct; 24 Suppl 3:331-5. PMID: 23114812. Abstract
Glial progenitor cell-based treatment and modeling of neurological disease. Goldman SA, Nedergaard M, Windrem MS Science. 2012 Oct 26; 338(6106):491-5. PMID: 23112326. Abstract
Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis. Dagley LF, Emili A, Purcell AW Proteomics Clin Appl. 2012 Oct 30. PMID: 23112123. Abstract
Constraint-Induced Movement Therapy for the Lower Extremities in Multiple Sclerosis: Case Series with 4-Year Follow-up. Mark VW, Taub E, Uswatte G, Bashir K, Cutter GR, Bryson CC, Bishop-McKay S, Bowman MH Arch Phys Med Rehabil. 2012 Oct 27. PMID: 23111280. Abstract
Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis. Brown RA, Narayanan S, Arnold DL Neuroimage. 2012 Oct 27. PMID: 23110887. Abstract
Type I IFN receptor controls activated TYK2 in the nucleus: Implications for EAE therapy. Ahmed CM, Noon-Song EN, Kemppainen K, Pascalli MP, Johnson HM J Neuroimmunol. 2012 Oct 27. PMID: 23110939. Abstract
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Pertwee RG Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5; 367(1607):3353-63. PMID: 23108552. Abstract
Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats. Das A, Kelly Guyton M, Smith A, Iv G W, McDowell ML, Holmes C, Matzelle DD, Ray SK, Banik NL J Neurochem. 2012 Oct 25. PMID: 23106593. Abstract
Paucity of natural killer and cytotoxic T cells in human neuromyelitis optica lesions. Saadoun S, Bridges LR, Verkman AS, Papadopoulos MC Neuroreport. 2012 Dec 19; 23(18):1044-7. PMID: 23108041. Abstract
The discovery of natalizumab, a potent therapeutic for multiple sclerosis. Steinman L J Cell Biol. 2012 Oct 29; 199(3):413-6. PMID: 23109666. Abstract
Epileptic seizures in multiple sclerosis: a population-based survey in Iran. Etemadifar M, Abtahi S-H, Roomizadeh P Acta Neurol Belg. 2012 Oct 31. Epub 2012 Oct 31. PMID: 23111776. Abstract
[2011: What's new in dysimmune neuropathies.] Kuntzer T Rev Neurol (Paris). 2012 Oct 26. PMID: 23107879. Abstract
Risk of venous thrombosis in patients with major illnesses: Results from the MEGA study. Ocak G, Vossen CY, Verduijn M, Dekker FW, Rosendaal FR, Cannegieter SC, Lijfering WM J Thromb Haemost. 2012 Oct 26. PMID: 23106832. Abstract
Myeloid microvesicles are a marker and therapeutic target for neuroinflammation. Verderio C, Muzio L, Turola E, Bergami A, Novellino L, Ruffini F, Riganti L, Corradini I, Francolini M, Garzetti L, et al. Ann Neurol. 2012 Oct; 72(4):610-24. PMID: 23109155. Abstract
Risk of fractures in patients with multiple sclerosis: A population-based cohort study. Dobson R, Ramagopalan S, Giovannoni G, Bazelier MT, de Vries F Neurology. 2012 Oct 30; 79(18):1934-5. PMID: 23109656. Abstract
Resident glial cell activation in response to perispinal inflammation leads to acute changes in nociceptive sensitivity: implications for the generation of neuropathic pain. Tenorio G, Kulkarni A, Kerr BJ Pain. 2012 Sep 27. PMID: 23103436. Abstract
Quantitative analysis of cerebrospinal fluid brain derived neurotrophic factor in the patients with multiple sclerosis. Mashayekhi F, Salehi Z, Jamalzadeh H R Acta Medica (Hradec Kralove). 2012; 55(2):83-6. PMID: 23101271. Abstract
Sleep disturbances in patients with multiple sclerosis. Pokryszko-Dragan A, Bilińska M, Gruszka E, Biel L, Kamińska K, Konieczna K Neurol Sci. 2012 Oct 30. Epub 2012 Oct 30. PMID: 23109097. Abstract
Estimating the proportion of variation in susceptibility to multiple sclerosis captured by common SNPs. Watson CT, Disanto G, Breden F, Giovannoni G, Ramagopalan SV Sci Rep. 2012; 2:770. Epub 2012 Oct 25. PMID: 23105968. Abstract
Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis? Mezei Z, Bereczki D, Racz L, Csiba L, Csepany T Neuropsychiatr Dis Treat. 2012; 8:465-73. Epub 2012 Oct 23. PMID: 23118540. Abstract
Consequences of neurologic lesions assessed by Barthel Index after Botox(®) injection may be underestimated. Dionyssiotis Y, Kiourtidis D, Karvouni A, Kaliontzoglou A, Kliafas I Ther Clin Risk Manag. 2012; 8:385-91. Epub 2012 Oct 19. PMID: 23112577. Abstract
Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters. Lee D-H, Gold R, Linker RA Int J Mol Sci. 2012; 13(9):11783-803. Epub 2012 Sep 18. PMID: 23109883. Abstract
Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. O'Gorman C, Lucas R, Taylor B Int J Mol Sci. 2012; 13(9):11718-52. Epub 2012 Sep 18. PMID: 23109880. Abstract
Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases. Hristodorov D, Mladenov R, Huhn M, Barth S, Thepen T Toxins (Basel). 2012 Sep; 4(9):676-94. Epub 2012 Sep 14. PMID: 23105975. Abstract
Erythropoietin: new directions for the nervous system. Maiese K, Chong Z Z, Shang Y C, Wang S Int J Mol Sci. 2012; 13(9):11102-29. Epub 2012 Sep 06. PMID: 23109841. Abstract
Prenatal vitamin d deficiency induces an early and more severe experimental autoimmune encephalomyelitis in the second generation. de Abreu D A F, Landel V, Barnett AG, McGrath J, Eyles D, Feron F Int J Mol Sci. 2012; 13(9):10911-9. Epub 2012 Aug 30. PMID: 23109828. Abstract